Tech Company Financing Transactions

SpecificiT Funding Round

On 9/12/2017, SpecificiT landed Seed funding from Accel-Rx Health Sciences Accelerator, AmorChem and Sanderling Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1010 Sherbrooke St. West 408
Montreal QC, H3A 2R7
Canada

Phone

(514) 700-0763

Website

www.specificitpharma.com

Email Address

[email protected]

Overview

SpecificiT Pharma Inc., a privately held biopharmaceutical company focused on developing innovative personalized cancer immunotherapies. SpecificiT is developing cellular therapies for hematological cancers which to date, cannot be treated with chimeric antigen receptor modified T cells (CAR-T) therapies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Pierre Beauparlant

        

Chief Financial Officer

Michael Dixon

        

Chief Operating Officer

Marc Lussier

        

VP - Manufacturing

Frederick Miesowicz

        

Browse more venture capital transactions:

Prev: 9/12/2017: Exagen Diagnostics venture capital transaction
Next: 9/12/2017: Aunt Fannie's venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary